Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Eskinder Tafesse"'
Autor:
Danai Bem, Daniel Sugrue, Ben Wilding, Ina Zile, Karin Butler, David Booth, Eskinder Tafesse, Phil McEwan
Publikováno v:
Renal Failure, Vol 43, Iss 1, Pp 241-254 (2021)
Background Patients with chronic kidney disease, especially those receiving hemodialysis (HD), are at risk of hyperkalemia (HK). This systematic review aimed to evaluate the prevalence of HK in patients with renal disease receiving HD and collate evi
Externí odkaz:
https://doaj.org/article/4584a040fda142f68bfd05e09ffb6326
Autor:
Diane Whalley, Gary Globe, Rebecca Crawford, Lynda Doward, Eskinder Tafesse, John Brazier, David Price
Publikováno v:
Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-14 (2018)
Abstract Background The increasing emphasis on patient-reported outcomes in health care decision making has prompted greater rigor in the evidence to support the instruments used. Acceptability and content validity are important properties of any mea
Externí odkaz:
https://doaj.org/article/17a113f666154e8c8bbac3d344fa651a
Autor:
Karin Butler, Phil McEwan, Ina Zile, David Booth, Ben Wilding, Danai Bem, Eskinder Tafesse, Daniel Sugrue
Publikováno v:
Renal Failure
article-version (VoR) Version of Record
Renal Failure, Vol 43, Iss 1, Pp 241-254 (2021)
article-version (VoR) Version of Record
Renal Failure, Vol 43, Iss 1, Pp 241-254 (2021)
Background Patients with chronic kidney disease, especially those receiving hemodialysis (HD), are at risk of hyperkalemia (HK). This systematic review aimed to evaluate the prevalence of HK in patients with renal disease receiving HD and collate evi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b26c1747bb9220beae1dc32b13701d
Autor:
L Hoskin, Philip Christopher McEwan, Daniel Sugrue, Glen James, Michael Hurst, Eskinder Tafesse, Karolina Badora
Publikováno v:
European Heart Journal. 41
Background Serum potassium (SK+) is a vital electrolyte, which level is maintained by adjusting renal K+ excretion. Variability in SK+ has been linked to increased risk of mortality and other adverse clinical events in patients in intensive care and/
Autor:
Karolina Badora, Philip Christopher McEwan, Daniel Sugrue, Michael Hurst, L Hoskin, Glen James, Eskinder Tafesse
Publikováno v:
European Heart Journal. 41
Background Hyper- and hypokalaemia are frequent complications in patients with heart failure (HF). The association between all-cause mortality (ACM), major adverse cardiovascular events (MACE) and serum potassium (K+) has previously been characterise
Autor:
Michael Hurst, Daniel Sugrue, Karolina Badora, L Hoskin, Glen James, Eskinder Tafesse, Philip Christopher McEwan
Publikováno v:
European Heart Journal. 41
Background Patients with chronic kidney disease (CKD), heart failure (HF), resistant hypertension (RHTN) and diabetes are at an increased risk of hyperkalaemia (HK) which can be potentially life-threatening, as a result of cardiac arrhythmias, cardia
Autor:
Karolina Badora, Michael Hurst, Phil McEwan, L Hoskin, Daniel Sugrue, Lei Qin, Glen James, Eskinder Tafesse
Publikováno v:
International journal of clinical practiceREFERENCES. 75(4)
INTRODUCTION Hyperkalaemia (HK) is associated with increased mortality risk. Prior studies suggest that the causes of HK are multifactorial. This study aimed to examine risk factors for incident and recurrent HK in six large real-world cohorts of UK
Autor:
Michael Hurst, Phil McEwan, Daniel Sugrue, L Hoskin, Glen James, Karolina Badora, Lei Qin, Eskinder Tafesse
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Patients with chronic kidney disease (CKD) are at increased risk of hyperkalaemia, HK (high serum potassium concentration) due to impaired renal function. This medical condition is potentially life threatening if untreated or poor
Autor:
Phil McEwan, Karolina Badora, Eskinder Tafesse, Lei Qin, Glen James, L Hoskin, Michael Hurst, Daniel Sugrue
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Approximately 275.9 million people globally and 5.6 million people in the UK are living with chronic kidney disease (CKD). The risk of hyperkalaemia (HK) is elevated in CKD due to renal impairment and may increase further upon tre
Autor:
Glen James, Karolina Badora, L Hoskin, Daniel Sugrue, Philip Christopher McEwan, Michael Hurst, Eskinder Tafesse
Publikováno v:
Value in Health. 23:S119